Search Results

Deals

Millendo Therapeutics Announces Successful Merger Completion with OvaScience, Inc

Merger with OvaScience Closed

December 7, 2018

·

9 min read

Policy

OvaScience Shareholders File Lawsuits to Stop Merger With Millendo Therapeutics

Shareholders raise concern over the fairness of the reverse merger and question potential conflicts of interest of OvaScience’s co-founder.

December 3, 2018

·

3 min read

·

Alex Keown

Business

OvaScience Pinks Slips Nearly 50% of Workforce

OvaScience provided a corporate update that includes initial data from a Phase I trial and news of extensive layoffs.

January 3, 2018

·

2 min read

·

Mark Terry

Business

OvaScience Reports Fourth Quarter and Year-End 2017 Financial Results

OvaScience reported financial results and provided a business update for the fourth quarter and year ended December 31, 2017.

March 15, 2018

·

8 min read

Deals

Beleaguered OvaScience is Absorbed in Reverse Merger by Michigan-based Millendo Therapeutics

Shares of struggling OvaScience have dipped 8 percent this morning after the company announced it entered into an all-stock reverse merger agreement with privately-held Millendo Therapeutics, Inc. of Ann Arbor, Mich.

August 9, 2018

·

2 min read

·

Alex Keown

Business

OvaScience Reports Third Quarter 2017 Financial Results

As of September 30, 2017, OvaScience had cash, cash equivalents and short-term investments of $75.7 million, compared to $114.4 million as of December 31, 2016.

November 2, 2017

·

10 min read

In-Vitro Fertilization Market to Reach US$ 725.9 Mn By the end of 2022, Increase in the demand for egg processing media to drive the market

Cook Medical, Vitrolife AB, CooperSurgical, EMD Serono, Inc., Genea Ltd., Fertility Focus Ltd., Thermo Fisher Scientific, Inc., Merck KGaA, Ovascience, Inc., Rocket Medical PLC, are some of the leading firms reigning the global in-vitro fertilization market.

March 16, 2022

·

5 min read

Business

OvaScience to Host Third Quarter 2017 Financial Results Conference Call

OvaScience announced today that it will host a conference call at 4:30 p.m. ET on Thursday, November 2, 2017 to discuss third quarter 2017 financial results and provide a general corporate update.

October 26, 2017

·

1 min read

Press Releases

Eikonizo Therapeutics Announces Investment by Novo Nordisk; Advancing Lead Candidate EKZ-102 Toward Clinical Development

December 10, 2024

·

5 min read

Deals

OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing

– New Commitment by Great Point Partners Brings Proceeds of Transactions to $87 Million –

November 1, 2018

·

11 min read